BioMarin Pharmaceutical Inc. buy melinda
Start price
07.09.18
/
50%
€88.42
Target price
20.09.18
€91.10
Performance (%)
3.04%
End price
20.09.18
€91.11
Summary
This prediction ended on 20.09.18 with a price of €91.11. With a performance of 3.04%, the BUY prediction by melinda for BioMarin Pharmaceutical Inc. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
BioMarin Pharmaceutical Inc. | 2.632% | 2.632% | 2.927% | 17.969% |
iShares Core DAX® | 1.776% | 3.175% | 14.882% | 17.660% |
iShares Nasdaq 100 | -1.037% | 1.869% | 35.463% | 52.324% |
iShares Nikkei 225® | -0.335% | 3.857% | 14.485% | 11.459% |
iShares S&P 500 | 0.854% | 2.567% | 31.105% | 47.441% |
Comments by melinda for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
SecteurProduits pharmaceutiques Agenda 12/09 | 19:05 Présentation
![Logo BioMarin Pharmaceutical Logo BioMarin Pharmaceutical](https://logos.cofisem.fr/US09061G1013.jpg)
- ventes de médicaments (96,7%) : destinés au traitement des troubles de surcharge lysosomale, de l'hyperphénylalaninémie et des maladies auto-immunes ;
- royalties et revenus issus d'accords de partenariat (3,3%).
A fin 2017, le groupe dispose d'un portefeuille de 6produits en phase de développement clinique.
La répartition géographique du CA est la suivante : Etats-Unis (44,8%), Europe (22,9%), Amérique latine (13,9%) et autres (18,4%).
Nombre d'employés : 2 581 personnes.
(Zielkurs erreicht)
Stopped prediction by melinda for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€62.00
29.09.19
29.09.19
€80.00
04.11.21
04.11.21
16.06%
05.11.21
05.11.21
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€71.88
28.03.18
28.03.18
€77.57
01.05.18
01.05.18
8.09%
01.05.18
01.05.18
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€75.61
08.11.17
08.11.17
€85.69
03.01.18
03.01.18
8.56%
03.01.18
03.01.18
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€83.83
08.11.17
08.11.17
€95.00
03.01.18
03.01.18
8.56%
03.01.18
03.01.18
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€77.73
27.01.17
27.01.17
€85.69
01.03.17
01.03.17
10.23%
01.03.17
01.03.17
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€82.62
10.07.16
10.07.16
€90.20
01.08.16
01.08.16
10.03%
01.08.16
01.08.16